Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2). (Q39119683)
Jump to navigation
Jump to search
scientific article published on 24 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2). |
scientific article published on 24 July 2013 |
Statements
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2) (English)
Diana P English
Stefania Bellone
Emiliano Cocco
Ileana Bortolomai
Sergio Pecorelli
Dan-Arin Silasi
Peter E Schwartz
Thomas Rutherford
Alessandro D Santin